• 1. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 2. Alumina coating on 5 V lithium cobalt fluorophosphate cathode material for lithium secondary batteries – synthesis and electrochemical properties?
  S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115
• 3. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 4. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 5. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives

Introduction to (2-(methyl-d3)pyrimidin-5-yl)boronic acid (CAS No. 2241865-77-8)

(2-(methyl-d3)pyrimidin-5-yl)boronic acid (CAS No. 2241865-77-8) is a deuterated boronic acid derivative that has gained significant attention in recent years due to its unique properties and potential applications in various fields, particularly in medicinal chemistry and materials science. This compound is characterized by its deuterium-labeled methyl group, which imparts enhanced stability and metabolic properties compared to its non-deuterated counterparts.

The structure of (2-(methyl-d3)pyrimidin-5-yl)boronic acid consists of a pyrimidine ring with a deuterated methyl group at the 2-position and a boronic acid moiety at the 5-position. The presence of deuterium atoms (D) instead of hydrogen atoms (H) can significantly affect the compound's chemical and physical properties, making it an attractive candidate for various research and industrial applications.

In medicinal chemistry, deuterated compounds like (2-(methyl-d3)pyrimidin-5-yl)boronic acid are often used to study the metabolic pathways of drugs and to develop more stable and effective therapeutic agents. Deuteration can slow down the metabolism of a drug, leading to improved pharmacokinetic profiles, reduced toxicity, and enhanced therapeutic efficacy. Recent studies have shown that deuterated boronic acids can be particularly useful in the development of prodrugs and targeted drug delivery systems.

One of the key applications of (2-(methyl-d3)pyrimidin-5-yl)boronic acid is in the field of cancer research. Boronic acids have been extensively studied for their ability to form covalent bonds with specific amino acids, such as cysteine, which are often found in the active sites of enzymes involved in cancer progression. By targeting these enzymes, boronic acids can inhibit their activity, leading to potential anti-cancer effects. The deuterated nature of (2-(methyl-d3)pyrimidin-5-yl)boronic acid may further enhance its stability and effectiveness as an inhibitor.

In addition to its pharmaceutical applications, (2-(methyl-d3)pyrimidin-5-yl)boronic acid has also found use in materials science. Boronic acids are known for their ability to form dynamic covalent bonds with diols, which can be utilized in the synthesis of self-healing materials and adaptive polymers. The deuterated version of this compound may offer improved thermal stability and mechanical properties, making it suitable for advanced material applications.

The synthesis of (2-(methyl-d3)pyrimidin-5-yl)boronic acid typically involves several steps, including the preparation of the deuterated methyl group and the subsequent coupling with a pyrimidine derivative followed by boronation. Recent advancements in synthetic methods have made it possible to produce this compound with high purity and yield, facilitating its widespread use in research and development.

From a safety perspective, (2-(methyl-d3)pyrimidin-5-yl)boronic acid is generally considered safe for laboratory use when proper handling procedures are followed. However, it is important to note that boronic acids can be sensitive to air and moisture, requiring careful storage conditions to maintain their stability and reactivity.

In conclusion, (2-(methyl-d3)pyrimidin-5-yl)boronic acid (CAS No. 2241865-77-8) is a versatile compound with a wide range of potential applications in medicinal chemistry, materials science, and other fields. Its unique properties, particularly those arising from its deuterated structure, make it an important tool for researchers aiming to develop more stable and effective compounds for various purposes. As research continues to advance, it is likely that new applications for this compound will be discovered, further expanding its utility and impact.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)